| Company Name: |
Haiji Pharmaceutical Technology (Suzhou) Co., Ltd
|
| Tel: |
18012778619 |
| Email: |
3394205705@qq.com |
| Products Intro: |
Product Name:Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester CAS:1950647-99-0 Purity:95% Package:1g/;5g/
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:HUN47990 CAS:1950647-99-0 Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
|
Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester manufacturers
- HUN47990
-
- $2500.00
-
2026-04-21
- CAS:1950647-99-0
- Purity:
- Supply Ability: 10g
|
| | Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester Basic information |
| Product Name: | Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester | | Synonyms: | Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester;HUN47990 | | CAS: | 1950647-99-0 | | MF: | C29H50N2O14P2S | | MW: | 744.73 | | EINECS: | | | Product Categories: | | | Mol File: | 1950647-99-0.mol | ![Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester Structure](CAS/20211123/GIF/1950647-99-0.gif) |
| | Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester Chemical Properties |
| Boiling point | 738.5±70.0 °C(Predicted) | | density | 1.256±0.06 g/cm3(Predicted) | | pka | 4.07±0.10(Predicted) |
| | Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester Usage And Synthesis |
| Description | HUN47990 is a bisphosphonate (BP) prodrug with antitumor activity. HUN47990 potently inhibits the in vitro growth of a variety of tumor cell lines, especially hematopoietic cell lines, at nanomolar concentrations. HUN47990 inhibited the prenylation of the RAP1A small GTPase signaling protein at concentrations as low as 1-10 nM. HUN47990 slowed the growth of human bladder cancer cells in an immunodeficient mouse model. HUN47990 is significantly more active than zoledronic acid, the most active FDA-approved BP, and a potential anti-cancer therapeutic. HUN47990 was first reported in ChemMedChem. 2016 Dec 16;11(24):2656-2663 (compound 7). This product has no formal name at the moment. |
| | Propanoic acid, 2,2-dimethyl-, 1,1′,1′′,1′′′-[[2-(2-thiazolylamino)ethylidene]bis[phosphinylidynebis(oxymethylene)]] ester Preparation Products And Raw materials |
|